Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy - Wikidata - wikimedia - TriplyDB

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy

http://www.wikidata.org/entity/Q37118392

about

Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy.Progesterone action in breast, uterine, and ovarian cancers.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway.Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma.Endometrial progesterone resistance and PCOS.The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.Epigenetic changes as prognostic predictors in endometrial carcinomas.FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.Reciprocal crosstalk between endometrial carcinoma and mesenchymal stem cells via transforming growth factor-β/transforming growth factor receptor and C-X-C motif chemokine ligand 12/C-X-C chemokine receptor type 4 aggravates malignant phenotypes.A novel therapeutic approach for treatment of catamenial epilepsy.Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT.Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway

P2860

Q33675285-0EB95BC5-5F65-41A5-B503-A2D326E58074 Q33813234-631B7490-8B62-42FD-96E9-A5DDB253C491 Q35108906-F30612DD-2844-4654-A21D-79F63AE0C35F Q35271188-4270869F-11B3-47A1-B9AB-F522E2A7F8C4 Q35739831-2B53EDCB-1CED-4CA4-B994-225707879A58 Q36586384-299B4C63-BB70-4FDA-B23F-B21FFA558FD3 Q36878675-354019A4-972D-4EA6-B7AB-D17FF4B10D05 Q37406760-380763EF-35B6-4924-9EB5-11F0EAA29800 Q37567264-62DDC3A4-4FE2-41E7-A162-3675363D0558 Q38691017-80298B93-1AFD-4D24-A5B3-9238A88A683C Q38788210-47643FAF-3AFF-4414-9FCA-4F293EA3148B Q39282288-EC2125CE-386A-4675-859E-232609FAA043 Q40462424-541E23DB-8B00-47B8-927D-53822CB98463 Q47112399-40C63B5B-755E-48CB-89F1-9858F4482E01 Q49259696-033E3151-F99A-473C-94DC-C6A1427111A4 Q49598739-1324E82F-2A55-480C-A017-5F1DE2F724E3 Q52751765-7FA096F8-DA24-4E5C-97BC-526A313EDF5F Q54968730-630AC42F-AAF7-4847-9342-51709505F07D Q58604035-B6D6EB46-1502-4A5D-95AC-83AB716FF109

P2860

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy

http://www.wikidata.org/entity/Q37118392

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Progesterone receptor signalin ...... s response to hormonal therapy

@en

Progesterone receptor signalin ...... response to hormonal therapy.

@nl

type

label

Progesterone receptor signalin ...... s response to hormonal therapy

@en

Progesterone receptor signalin ...... response to hormonal therapy.

@nl

prefLabel

Progesterone receptor signalin ...... s response to hormonal therapy

@en

Progesterone receptor signalin ...... response to hormonal therapy.

@nl

P1433

Q37118392-229516E9-6A54-4DA4-9357-47F9D56D911B

P1476

Q37118392-7E9640ED-7C45-4AA0-A81C-089CD6226644

P2093

Q37118392-07B66286-1C2E-4AEC-BDB6-E08E4C9EFFDD

Q37118392-31C9C09D-81AA-4A03-B034-466E520E32D4

Q37118392-449B194F-6168-4B0D-AC40-D60FAB03AF09

Q37118392-76294B55-18DD-4460-A5C1-5DE46850F5A1

Q37118392-83D26F3B-BCEF-44D9-B262-CCB91B4E3B6F

Q37118392-AAAA2931-23CF-44B9-B587-4F2ACFCEDA7B

Q37118392-E474CC95-256D-4741-95AA-D783BB019ED2

Q37118392-FE6D0569-7070-4943-B513-90F4351B00E3

P2860

Q37118392-028578A9-D737-4955-ACD6-77DDDE280D98

Q37118392-04130487-3D7B-40A0-A385-1294F7FC2110

Q37118392-0DF24A6C-C349-49EC-86AD-108B002B3893

Q37118392-11CD6653-6FD2-4F62-A0E9-CE36A1B6CF78

Q37118392-184C8674-7664-4AA1-A77A-E61B9BABB967

Q37118392-1909BDD3-8D57-4D0D-BA9B-D68A4EA21D58

Q37118392-1F1C5FE2-02CC-4B67-881F-C3708AA42FBC

Q37118392-2AD3A8CF-EAC1-4CEA-AC53-26FC9A1850A6

Q37118392-2EDD493E-1C8B-4202-B901-697F337DF37E

Q37118392-38B94349-5C7A-4E25-9F3F-77D300604D83

P304

Q37118392-8BC783DA-23D0-4FBC-9C46-6A0225C9F66D

P31

Q37118392-A53FB25C-0126-4072-A961-FA3B620EDBAE

P356

Q37118392-1E6908E8-3FE9-4B93-89AE-980AF2CE4E58

P407

Q37118392-925754B9-9531-4FBA-B818-A7505BB2493C

P433

Q37118392-69CE28B9-F5E0-49F0-AAF8-85973448FD8D

P478

Q37118392-8E23059A-E812-4148-9732-686188324C0A

P577

Q37118392-4D01F449-CD88-4744-96BD-1E3B015E46F0

P698

Q37118392-F9F056B3-AA34-4BC2-A611-F8D1C8637D73

P932

Q37118392-FA5056A1-DB98-4594-BA84-E01EB8A0F6F5

P356

0008-5472.CAN-13-0930

P1433

Cancer Research

P1476

Progesterone receptor signalin ...... s response to hormonal therapy

@en

P2093

Daniel A Smith

http://www.w3.org/2001/XMLSchema#string

Daniel S Lee

http://www.w3.org/2001/XMLSchema#string

Daniel Y Paik

http://www.w3.org/2001/XMLSchema#string

Deanna M Janzen

http://www.w3.org/2001/XMLSchema#string

M Luisa Iruela-Arispe

http://www.w3.org/2001/XMLSchema#string

Miguel A Rosales

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

Sanaz Memarzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2

Cancer statistics, 2013

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.

Role of progesterone in endometrial cancer

Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor

Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.

Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.

P304

4697-4710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-13-0930

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23744837

http://www.w3.org/2001/XMLSchema#string

P932

3752407

http://www.w3.org/2001/XMLSchema#string